| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |